Back
About the Global Fund
Overview
Results & Impact
Financials
Strategy
Resource Mobilization
Partners & StructuresPeople & Structures
Funding Model
Grant Portfolio
Countries
Multicountry programs
HIV/AIDS
Tuberculosis
MalariaNews & Stories
-
Global Fund Praises African Leadership on Investing in Health
10 February 2019Global Fund Applauds Major Increase in Contribution from Ireland
09 February 2019
Feature Stories
Updates
- Audit of Global Fund Human Resources Management Processes
- Message from the Executive Director - Investigation in Democratic Republic of Congo
- Investigation in Democratic Republic of Congo
- Strategic Framework for Data Use for Action and Improvement at Country Level
- Audit of Grants in Benin
- Updated Partner Portal Guidance
Publications
Documents By Type
Sourcing & Management of Health Products
Information Notice
The Global Fund’s quality assurance information notices provide guidance and advice on how to operationalize in practical terms the consequences of a quality or a safety issue related to a product that has been procured with Global Fund funds. The initial information, stated in the notice, comes from the manufacturer of health products in question and/or is confirmed by stringent regulatory mechanisms.
-
Information Notices
-
QA Information Notice 2019-01: Quality issues with DawaPlus 2.0 commercialized by Tana Nettings Co Ltd manufactured by H. Sheikh Noorud- Din & Sons (HSNDS)
download in English -
QA Information Notice 2018-07: Suspension of Dongkuk Viet Nam Co., Ltd. from the WHO/UNFPA list of prequalified male latex condom manufacturer
download in English -
QA Information Notice 2018-06: Unlawfully displayed ACTm logo on boxes of Lesanto Laboratories
download in English -
QA Information Notice 2018-05-Falsified Combiart : Artemether 20 mg + Lumefantrine 120 mg tablets
download in English -
Quality Assurance Information Notice 2018-03 (update 1 October 2018): Eligibility Reinstated for Products Manufactured by Diagnostics for the Real World - SAMBA HIV-1 Semi-Q Test for use with SAMBA I Instrument and SAMBA II HIV-1 Semi-Q Test for use with SAMBA II Instrument
download in English -
Quality Assurance Information Notice 2018-04: REMEDICA Rapid Alert Notification CY/I/07/01: Falsified Quinine Sulphate tablets 300 mg
download in English | Français -
Quality Assurance Information Notice 2018-03: Temporary Delisting of Products Manufactured by Diagnostics for the Real World - SAMBA HIV-1 Semi-Q Test for use with SAMBA I Instrument and SAMBA II HIV-1 Semi-Q Test for use with SAMABA II Instrument
download in English -
Quality Assurance Information Notice 2018-02: Dolutegravir (DTG) Use in Women of Childbearing Age – Safety Communication (8 June 2018)
download in English -
Quality Assurance Information Notice 2018-01: Briefing on the Recent Changes to the Global Fund Quality Assurance Policy for Diagnostic Products with Regards to the Procurement and Testing of Malaria Rapid Diagnostic Test (RDTs)
download in English -
Quality Assurance Information Notice 2016-01: All Products Manufactured by Svizera Labs Private Limited, Turbhe, Navi, Mumbai, India - Eligibility Reinstated for Procurement with Global Fund Funds
download in English -
Quality Assurance Information Notice 2017-01: Voluntary Recall Initiated by Lupin for Isoniazid Tablets BP 100mg, Batches No A301856, A302231, A302408
download in English | Español | Français -
Quality Assurance Information Notice 2016-04: Remedica Product: Sulfadoxine / Pyrimethamine, 500/25 mg, Tablets - Eligibility Reinstated for Procurement with Global Fund Funds
download in English -
Quality Assurance Information Notice 2016-03: Hetero Labs Product: Efavirenz, Lamivudine, and Tenofovir, 600/300/300 mg Tablets - No Longer Eligible for Procurement with Global Fund Funds
download in English | Español | Français -
Quality Assurance Information Notice 2016-02: Recommendations Regarding the Procurement and the Distribution of Finished Pharmaceutical Products Using Active Pharmaceutical Ingredients Manufactured at IPCA Ratlam Manufacturing Site
download in English | Español | Français -
Quality Assurance Information Notice 2016-01: Recommendations Following WHO PQP Suspension of all the Prequalified Products Manufactured by Svizera Labs Private Limited
download in English
-
QA Information Notice 2019-01: Quality issues with DawaPlus 2.0 commercialized by Tana Nettings Co Ltd manufactured by H. Sheikh Noorud- Din & Sons (HSNDS)
The Global Fund uses cookies for anonymized statistics on website use and content performance. These statistics help us improve and adapt the website for our users.
Please click on "Accept" to agree with the use of these cookies.
To learn more, please read the Privacy Statement.